28 results
424B5
DAWN
Day One Biopharmaceuticals Inc
7 Jun 23
Prospectus supplement for primary offering
4:57pm
of the COVID-19 pandemic, increase in inflation and changes in interest rates, and disruptions to the supply chain, that have been often unrelated
424B5
pyi mzo3t
6 Jun 23
Prospectus supplement for primary offering
4:21pm
8-K
EX-99.2
hky8en44
4 Aug 22
Day One Reports Second Quarter 2022 Financial Results and Corporate Progress
4:53pm
8-K
EX-99.1
65hym 1ualz6o7c
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:06pm
424B5
7m21es25iwdzlo97mzt
16 Jun 22
Prospectus supplement for primary offering
7:30am
424B5
et430b8o
14 Jun 22
Prospectus supplement for primary offering
7:39am
8-K
EX-99.2
0jeu13b21p
13 Jun 22
Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma
6:24am
8-K
EX-99.2
m5dqjirp179f5
12 May 22
Day One Reports First Quarter 2022 Financial Results and Provides Business Update
4:33pm
8-K
EX-99.1
ymqbq5mbt ok0p4
13 Apr 22
Targeted Therapies for People of All Ages April 2022
8:01am
10-K
piq36ocnjtdh5fmtfy2
7 Mar 22
Annual report
7:36am
8-K
EX-99.2
2o342mk
7 Mar 22
Day One Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Progress
7:30am
8-K
EX-99.2
yjutots4r1z62
5 Jan 22
Day One to Present at the 40th Annual J.P. Morgan Healthcare Conference
8:01am